Mr Crew has been a Consultant Urologist in Oxford and Banbury for 20 years. He has extensive experience in managing all urological conditions in particular the management of haematuria, pelvic cancer, PSA and Benign Prostatic Hyperplasia (BPH).
He has a national and international reputation for the management of haematuria and bladder cancer and offers the full range of treatments for these conditions.
Mr Crew has been involved in the management of the PSA blood test and prostate cancer. He provides an unbiased view of the benefits of PSA testing, abnormal PSA’s and options for diagnosis and management of prostate cancer.
Mr Crew has a long-time interest in the management of BPH and male urinary tract symptoms. He has expertise in all management options including Holmium laser enucleation of the prostate (HOLEP), Prostatic Artery Embolization (PAE), Rezum treatment and Urolift. He is happy to guide patients through the different options available and offer experienced advice.
Mr Crew has been performing vasectomy’s for over 25 years and vasectomy reversals for 18 years. He is able to give advice to patients on these two management options.
- Wednesday 1-4pm
- Friday 2-5pm
- Tuesday & Thursday Afternoon by Arrangement
- Consultant Urological Surgeons Oxford University Hospitals NHS Foundation Trust (Oxford & Banbury)
- General urology
- Pelvic cancer
- Management of Haematuria
- Management of BPH
- Endoscopic Kidney Stone Treatment
- Holmium laser enucleation of the prostate (HoLEP)
- Prostate laser treatment
- Prostate Resection (TURP)
- Prostate Surgery
- Transurethral resection of bladder tumour (TURBT)
- Vasectomy Reversal
- Management of raised PSA
- Management of Haematuria
- Newer management for BPH including Urolift, PAE & Rezum
Family, Keeping Fit, Running, Golf
- British Association of Urological Surgeons (BAUS)
- British Medical Association
- American Urological Association
- British Association of Urological Surgeon (Uro-oncology Section)
- General Medical Council
- British Association of Urological Surgeon (Endourology Section)
Mr Crew has been involved in research for over 20 years having been awarded a Doctor of Medicine degree for his thesis on ‘Angiogenesis in Bladder Cancer’ in 1998. For this work he was awarded the Sir Langdon Browne Prize from Cambridge University and the European Association of Urology Thesis Award.
Mr Crew has continued to be involved in research through his involvement in national and International clinical trials as either the Principle or Chief Investigator.
Most Recently Mr Crews research focus has been on;
1] The use of newer immunotherapeutic agents in the management of bladder cancer.
2] New treatment and management options for bladder cancer
3] The role of new modalities in the management of men with benign prostatic hyperplasia (BPH)
DeclarationMr Jeremy Crew works with the following private medical insurance providers:
- Aviva Health
- AXA PPP Healthcare
- AXA PPP International
- Benenden Health
- Bupa On Demand
- CS Healthcare
- The Exeter Friendly
- Universal Provident
- Vitality Health (Pru Health)
- Westfield Health WPA
Mr Jeremy Crew does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Mr Jeremy Crew does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Mr Jeremy Crew does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.